Hypercholesterolaemia: optimal treatment by next-generation drugs?

[摘要] Statins are the current standard treatment of patients with hypercholesterolaemia. These drugs have been shown to be very effective in reducing the incidence of cardiovascular disease [1, 2]. Nevertheless, a substantial number of patients do not achieve their target low-density lipid protein cholesterol (LDL-C) levels. Consequently, new treatment options are required to decrease LDL-C levels beyond those currently achieved.

[学科分类] 心脏病和心血管学